CA
NMTR

CoreCap Advisors’s 9 Meters Biopharma NMTR Stock Holding History

CoreCap Advisors’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$127 Buy
+101
New +$230 ﹤0.01% 2298
2022
Q3 		– Sell
-101
Closed -$1K – 2278
2022
Q2 		$1K Buy
+101
New +$952 ﹤0.01% 2100
2022
Q1 		– Sell
-301
Closed -$6K – 2275
2021
Q4 		$6K Buy
+301
New +$6.73K ﹤0.01% 1728

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

CoreCap Advisors's NMTR Position: Q4 2022 in Review

CoreCap Advisors opened a new position in 9 Meters Biopharma (NMTR) in Q4 2022: 101 shares worth $127. The stake represents ﹤0.01% of the portfolio and ranks #2298 among its holdings. This is a return to the name: CoreCap Advisors previously reported a position in NMTR as recently as Q2 2022.

CoreCap Advisors first reported a position in NMTR in Q4 2021 and has held it in 3 quarters since. The position peaked at $6K in Q4 2021. 42 funds tracked by Wall St. Rank hold NMTR as of Q4 2022.

  • CoreCap Advisors held 101 shares of 9 Meters Biopharma worth $127 as of Q4 2022.
  • 9 Meters Biopharma was a new CoreCap Advisors position in Q4 2022.
  • 9 Meters Biopharma made up ﹤0.01% of CoreCap Advisors's portfolio in Q4 2022, its #2298 holding.
  • CoreCap Advisors first reported a position in 9 Meters Biopharma in Q4 2021 and has held it in 3 quarters since.
  • CoreCap Advisors's 9 Meters Biopharma position peaked at $6K in Q4 2021.
  • 42 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2022.

Based on CoreCap Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.